Background: Endometrial carcinoma is the most common gynecologic malignancy in women and frequently presents with postmenopausal bleeding. Accurate preoperative staging is essential for determining appropriate treatment and predicting prognosis. Magnetic resonance imaging (MRI) with its superior soft-tissue contrast has emerged as the modality of choice for preoperative evaluation. Aim: To evaluate the role of MRI in preoperative assessment and FIGO staging of endometrial carcinoma and to correlate imaging findings with histopathological reports. Methods: A retrospective observational study was conducted at the Department of Radio diagnosis, IGGMCH Nagpur from November 2020 to December 2025, including 16 patients with histologically confirmed or imaging-suspected endometrial carcinoma who underwent contrast-enhanced MRI of the pelvis. MRI findings were assessed for tumor size, depth of myometrial invasion, cervical stromal involvement, parametrial extension, adnexal spread, pelvic/para-aortic lymphadenopathy and FIGO staging. Results: The mean patient age was 58 years (range 35–65 years). Postmenopausal bleeding was the predominant presenting symptom. MRI detected an endometrial mass in all 16 cases. Superficial myometrial invasion (<50%) was noted in 37.5% (n=6) and deep invasion (≥50%) in 31.25% (n=5) of cases. Cervical stromal involvement was identified in 31.25% (n=5). FIGO staging distribution: Stage IA – 31.25%, Stage IB – 18.75%, Stage II – 25%, Stage III – 12.5%, Stage IVB – 12.5%. Conclusion: MRI is a reliable and indispensable imaging modality for preoperative staging of endometrial carcinoma. It accurately delineates tumor extent, depth of myometrial invasion, cervical stromal involvement and extra uterine spread, thereby guiding surgical planning and adjuvant therapy decisions.